Trusted mental health care at your fingertips
Our digital treatments are safe and effective non-drug options for insomnia and anxiety*, available free in Scotland and some parts of England - no prescription required.
Medication isn't the only option
1 in 8 adults in the UK are prescribed medication for their mental health - but medication isn't always the best option.
58% of people experience moderately severe side effects.2
Less than 50% remission rate for the most common medications.3,4
75% of people prefer a non-drug option.5
Treatments that change lives
Our treatments are not just another app on your phone. They’re the feeling of finally getting a good night’s sleep and waking up with enough energy for the day. They’re the difference between managing and thriving. They’re there for you whenever and wherever you need them.
We're trusted by over 170,000 patients in the UK, so you can be sure you're in safe hands with us.
Get better sleep
Improve sleep with Sleepio, a six-week cognitive behavioural therapy programme clinically proven to treat insomnia.
Tackle anxiety
and worry
Overcome stress and worries with Daylight, a cognitive behavioural therapy programme clinically proven to treat anxiety and worry.
Access treatment instantly
Insomnia and anxiety treatments backed by science and research
We’re committed to gold-standard clinical evidence. We have 64 publications with more than 28,000 participants, including 13 randomised controlled trials (RCTs).
1. Lubian, K., Weich, S., Stansfeld, S., Bebbington, P., Brugha, T., Spiers, N. & Cooper, C. (2016). Chapter 3: Mental health treatment and services. In S. McManus, P. Bebbington, R. Jenkins, & T. Brugha (Eds.), Mental health and wellbeing in England: Adult Psychiatric Morbidity Survey 2014. Leeds: NHS Digital.
2. Lembke, A., Papac, J., & Humphreys, K. (2018). Our other prescription drug problem. The New England journal of medicine, 378(8), 693-695.
3. Pillai, V., Roth, T., Roehrs, T., Moss, K., Peterson, E. L., & Drake, C. L. (2017). Effectiveness of benzodiazepine receptor agonists in the treatment of insomnia: an examination of response and remission rates. Sleep, 40(2), zsw044.
4. Rickels, K., & Rynn, M. (2002). Pharmacotherapy of generalized anxiety disorder. The Journal of clinical psychiatry, 63(suppl 14), 9-16.
5. McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013). Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. The Journal of clinical psychiatry, 74(6), 0-0.